Jennelle C Hodge
Overview
Explore the profile of Jennelle C Hodge including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
49
Citations
2167
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mascho K, Yatsenko S, Lo C, Xu X, Johnson J, Helvaty L, et al.
Front Genet
. 2024 Nov;
15:1451746.
PMID: 39492880
Introduction: 5p deletion syndrome, also called Cri-du-chat syndrome 5p is a rare genetic syndrome with reports up to 36% of patients are associated with congenital heart defects. We investigated the...
2.
Shugg T, Tillman E, Breman A, Hodge J, McDonald C, Ly R, et al.
Clin Pharmacol Ther
. 2024 Aug;
116(4):914-931.
PMID: 39169556
In 2019, Indiana University launched the Precision Health Initiative to enhance the institutional adoption of precision medicine, including pharmacogenetics (PGx) implementation, at university-affiliated practice sites across Indiana. The overarching goal...
3.
Milman T, Grossniklaus H, Goldman-Levy G, Kivela T, Coupland S, White V, et al.
Ocul Oncol Pathol
. 2023 Oct;
9(3-4):71-95.
PMID: 37900189
No abstract available.
4.
Landis B, Helvaty L, Geddes G, Lin J, Yatsenko S, Lo C, et al.
J Am Heart Assoc
. 2023 Sep;
12(18):e029340.
PMID: 37681527
Background Chromosomal microarray analysis (CMA) provides an opportunity to understand genetic causes of congenital heart disease (CHD). The methods for describing cardiac phenotypes in patients with CMA abnormalities have been...
5.
Lowther C, Valkanas E, Giordano J, Wang H, Currall B, OKeefe K, et al.
Am J Hum Genet
. 2023 Aug;
110(9):1454-1469.
PMID: 37595579
Short-read genome sequencing (GS) holds the promise of becoming the primary diagnostic approach for the assessment of autism spectrum disorder (ASD) and fetal structural anomalies (FSAs). However, few studies have...
6.
Shugg T, Ly R, Osei W, Rowe E, Granfield C, Lynnes T, et al.
Front Oncol
. 2023 Jul;
13:1199741.
PMID: 37469403
Background: Next-generation sequencing (NGS), including whole genome sequencing (WGS) and whole exome sequencing (WES), is increasingly being used for clinic care. While NGS data have the potential to be repurposed...
7.
Gaedigk A, Boone E, Turner A, van Schaik R, Chernova D, Wang W, et al.
J Mol Diagn
. 2023 Jun;
25(9):655-664.
PMID: 37354993
Pharmacogenetic testing for CYP3A4 is increasingly provided by clinical and research laboratories; however, only a limited number of quality control and reference materials are currently available for many of the...
8.
Iwata-Otsubo A, Darr K, Torres-Martinez W, Hodge J
Cytogenet Genome Res
. 2022 Dec;
162(5):237-243.
PMID: 36516793
Brachydactyly mental retardation syndrome (BDMR) typically results from large deletions (>2-9 Mb) in distal 2q37. Haploinsufficiency of HDAC4 with incomplete penetrance has been proposed as the primary genetic cause of...
9.
Collins R, Glessner J, Porcu E, Lepamets M, Brandon R, Lauricella C, et al.
Cell
. 2022 Aug;
185(16):3041-3055.e25.
PMID: 35917817
Rare copy-number variants (rCNVs) include deletions and duplications that occur infrequently in the global human population and can confer substantial risk for disease. In this study, we aimed to quantify...
10.
Khoury J, Solary E, Abla O, Akkari Y, Alaggio R, Apperley J, et al.
Leukemia
. 2022 Jun;
36(7):1703-1719.
PMID: 35732831
The upcoming 5th edition of the World Health Organization (WHO) Classification of Haematolymphoid Tumours is part of an effort to hierarchically catalogue human cancers arising in various organ systems within...